|
 |
|
Regional News |
| Print |
|
E-mail
|
|
 Biotech 2008 has partnered with Business Wire to bring you a live news feed of bioscience headlines from Delaware, New Jersey, and Pennsylvania.
|
|
 |
-
Merck to Hold Fourth-Quarter 2008 Sales and Earnings Conference Call on Feb. 3
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co., Inc. will hold its fourth-quarter 2008 sales and earnings conference call with institutional investors and analysts beginning at 9 a.m. EST on Tuesday, Feb.
-
AmerisourceBergen Announces Date and Time for Fiscal First Quarter Earnings Release
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE:ABC) today announced that it plans to release its results for the First Quarter of Fiscal Year 2009 on Thursday, January 22, 2009 prior to the
-
Quinnova Pharmaceuticals, Inc. Launches Neosalus
NEWTOWN, Pa.--(BUSINESS WIRE)--Quinnova Pharmaceuticals, Inc. announced today the launch of Neosalus, the first non-steroidal anti-inflammatory prescription topical foam product for the treatment of various types of
-
Quinnova Pharmaceuticals, Inc. Launches Salvax (Hydrating Topical Foam)
NEWTOWN, Pa.--(BUSINESS WIRE)--Quinnova Pharmaceuticals, Inc. announced today the launch of Salvax (Hydrating Topical Foam) Rx for the treatment of hyperkeratotic conditions such as psoriasis, keratosis pilaris, and
-
OraSure Technologies to Participate at the Eleventh Annual Needham Growth Conference
BETHLEHEM, Pa.--(BUSINESS WIRE)--OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and Chief Executive Officer, will speak to the investment community at the Eleventh Annual
-
dbMotion Expands North American Executive Management Team
PITTSBURGH--(BUSINESS WIRE)--dbMotion, a provider of health interoperability and intelligence solutions, has expanded its North American executive management team to meet the increasing demand for innovative HIT
-
Genta Summarizes Phase 2 Activity and Receives Orphan Drug Designation in Gastric Cancer for Tesetaxel, a Leading Oral Taxane in Clinical Development
BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Genta Incorporated (OTCBB: GNTA) announced today that the Company has received notice from the U.S. Food and Drug Administration (FDA) that tesetaxel, the latest addition to
-
Trevena, Inc. Named by BusinessWeek as One of the ?Most Successful U.S. Startups 2008?
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena Inc., a biotechnology company focused on discovery of a new generation of drugs that target G-protein coupled receptors, announced today that BusinessWeek magazine
-
One Million Americans Now Receive Personalized FDA Drug Safety Alerts Through iGuard.org
PRINCETON, N.J.--(BUSINESS WIRE)--Today, iGuard.org, a free and secure medication monitoring service, registered its one-millionth member just 14 months after its launch last year. iGuard.org’s rapid growth
-
Actavis Acquires Kadian; Extends Specialty Drug Portfolio in U.S.
MORRISTOWN, N.J.--(BUSINESS WIRE)--Actavis today announced that it has acquired the brand name drug Kadian® from King Pharmaceuticals for not more than USD127.5M, based on quarterly sales related milestones,
-
Dynasil Announces Fiscal Year 2008 Results
WEST BERLIN, N.J.--(BUSINESS WIRE)--Dynasil Corporation of America (OTCBB:DYSL.OB), announced the results of operations for its fiscal year ended September 30, 2008. Dynasil is a manufacturer of photonic products
|
|
|
|
|
|
